Arcadia Biosciences, Inc.
RKDA- Exchange
- Nasdaq
- Industry
- Crude Petroleum & Natural Gas
- SEC CIK
- 0001469443
No open-market purchases or sales by Arcadia Biosciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $146.5K in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Arcadia Biosciences, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 15 | 14 | −1 |
| Shares | 138.5K | 81.0K | −57.6K (−41.6%) |
| Value | $430.7K | $178.3K | −$252.4K (−58.6%) |
New holders (2)
Institutions that held Arcadia Biosciences, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 10,453 | $23.0K | 0.00% |
| UBS Group AG | 2 | $4 | 0.00% |
Sold out (3)
Institutions that held Arcadia Biosciences, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Virtu Financial LLC | 11,370 | $34.0K |
| JPMorgan Chase & Co | 508 | $1.54K |
| BlackRock Inc. | 38 | $119 |